Citadel Advisors
SPPI

Citadel Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Citadel Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$96 – 15576
2023
Q2 		$96 Buy
+100
New +$99 ﹤0.01% 14224
2023
Q1 		– Sell
-296,392
Closed -$216K – 15915
2022
Q4 		$109K Buy
+296,392
New +$125K ﹤0.01% 11098
2022
Q3 		– Sell
-755,128
Closed -$742K – 13993
2022
Q2 		$589K Buy
755,128
+741,215
+5,327% +$653K ﹤0.01% 8279
2022
Q1 		$18K Sell
13,913
-502,006
-97% -$462K ﹤0.01% 13278
2021
Q4 		$655K Buy
515,919
+495,584
+2,437% +$886K ﹤0.01% 9009
2021
Q3 		$44K Sell
20,335
-131,339
-87% -$359K ﹤0.01% 13434
2021
Q2 		$569K Buy
151,674
+45,588
+43% +$158K ﹤0.01% 9774
2021
Q1 		$346K Sell
106,086
-168,873
-61% -$605K ﹤0.01% 10516
2020
Q4 		$937K Buy
+274,959
New +$1.13M ﹤0.01% 6931
2020
Q3 		– Sell
-404,615
Closed -$1.54M – 10958
2020
Q2 		$1.37M Buy
404,615
+346,366
+595% +$1.01M ﹤0.01% 5251
2020
Q1 		$136K Sell
58,249
-18,963
-25% -$51.9K ﹤0.01% 8381
2019
Q4 		$281K Buy
77,212
+52,383
+211% +$423K ﹤0.01% 7686
2019
Q3 		$206K Sell
24,829
-794,783
-97% -$6.43M ﹤0.01% 8114
2019
Q2 		$7.06M Buy
819,612
+476,983
+139% +$4.27M ﹤0.01% 2621
2019
Q1 		$3.66M Buy
342,629
+161,935
+90% +$1.73M ﹤0.01% 3445
2018
Q4 		$1.58M Sell
180,694
-1,390,037
-88% -$17.7M ﹤0.01% 4539
2018
Q3 		$26.4M Buy
1,570,731
+307,667
+24% +$6.66M 0.01% 1172
2018
Q2 		$26.5M Buy
1,263,064
+1,206,063
+2,116% +$22.3M 0.01% 1092
2018
Q1 		$917K Buy
+57,001
New +$1.13M ﹤0.01% 4957
2017
Q4 		– Sell
-82,514
Closed -$1.49M – 8580
2017
Q3 		$1.16M Sell
82,514
-32,400
-28% -$293K ﹤0.01% 4110
2017
Q2 		$856K Sell
114,914
-248,535
-68% -$1.62M ﹤0.01% 4318
2017
Q1 		$2.36M Sell
363,449
-236,933
-39% -$1.32M ﹤0.01% 2882
2016
Q4 		$2.66M Buy
600,382
+436,568
+267% +$1.83M ﹤0.01% 2626
2016
Q3 		$766K Buy
163,814
+54,289
+50% +$322K ﹤0.01% 4189
2016
Q2 		$720K Buy
+109,525
New +$774K ﹤0.01% 3994
2016
Q1 		– Sell
-9,505
Closed -$48.8K – 8269
2015
Q4 		$57K Sell
9,505
-27,213
-74% -$156K ﹤0.01% 7207
2015
Q3 		$219K Buy
+36,718
New +$255K ﹤0.01% 6026
2015
Q2 		– Sell
-1,069,827
Closed -$6.79M – 9190
2015
Q1 		$6.49M Buy
1,069,827
+976,883
+1,051% +$6.5M 0.01% 1779
2014
Q4 		$644K Sell
92,944
-238,987
-72% -$1.76M ﹤0.01% 4359
2014
Q3 		$2.7M Buy
331,931
+273,202
+465% +$2.14M ﹤0.01% 2550
2014
Q2 		$477K Sell
58,729
-18,974
-24% -$144K ﹤0.01% 4460
2014
Q1 		$609K Buy
77,703
+39,587
+104% +$335K ﹤0.01% 4066
2013
Q4 		$337K Buy
38,116
+11,197
+42% +$100K ﹤0.01% 4481
2013
Q3 		$226K Sell
26,919
-6,057
-18% -$49K ﹤0.01% 4651
2013
Q2 		$246K Buy
+32,976
New +$253K ﹤0.01% 4478

Citadel Advisors's SPPI Position: Q3 2023 in Review

Citadel Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 100 shares — an estimated $96 sold.

Citadel Advisors first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $26.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Citadel Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 100 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $96.
  • Citadel Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
  • Citadel Advisors's Spectrum Pharmaceuticals Inc position peaked at $26.5M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.